HUP9900511A2 - Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás - Google Patents

Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás

Info

Publication number
HUP9900511A2
HUP9900511A2 HU9900511A HUP9900511A HUP9900511A2 HU P9900511 A2 HUP9900511 A2 HU P9900511A2 HU 9900511 A HU9900511 A HU 9900511A HU P9900511 A HUP9900511 A HU P9900511A HU P9900511 A2 HUP9900511 A2 HU P9900511A2
Authority
HU
Hungary
Prior art keywords
adrenergic agonist
cosmetical
beta
treating
substance
Prior art date
Application number
HU9900511A
Other languages
English (en)
Inventor
Michel Breton
Olivier De Lacharriere
Jacques Leclaire
Original Assignee
L'oreal
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by L'oreal filed Critical L'oreal
Publication of HUP9900511A2 publication Critical patent/HUP9900511A2/hu
Publication of HUP9900511A3 publication Critical patent/HUP9900511A3/hu

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/41—Amines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A61K31/137—Arylalkylamines, e.g. amphetamine, epinephrine, salbutamol, ephedrine or methadone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/16—Emollients or protectives, e.g. against radiation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q5/00—Preparations for care of the hair
    • A61Q5/02—Preparations for cleaning the hair
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients
    • A61K2800/75—Anti-irritant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Birds (AREA)
  • Emergency Medicine (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)

Abstract

A találmány legalább egy -adrenergiás agőnista mint P anyagantagőnista alkalmazására vőnatkőzik kőzmetikai készítményekben vagygyógyszerkészítmény előállításánál, amely készítmények alkalmasakkülönböző, a P anyag főkőzőtt szintézisével és/vagy felszabadűlásávalkapcsőlatős elváltőzásők kezelésére. A találmány vőnatkőzik tővábbákőzmetikai kezelési eljárásra is, amelynél legalább egy -adrenergiásagőnistát tartalmazó készítményt visznek fel a bőrre, hajra és/vagy anyálkamembránőkra. ŕ
HU9900511A 1995-10-23 1996-10-01 Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating HUP9900511A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9512447A FR2740040B1 (fr) 1995-10-23 1995-10-23 Utilisation d'au moins un agoniste beta-adrenergique en tant qu'antagoniste de substance p

Publications (2)

Publication Number Publication Date
HUP9900511A2 true HUP9900511A2 (hu) 1999-07-28
HUP9900511A3 HUP9900511A3 (en) 2000-09-28

Family

ID=9483809

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9900511A HUP9900511A3 (en) 1995-10-23 1996-10-01 Use of at least one beta-adrenergic agonist as a p substance antagonist and process for cosmetical treating

Country Status (14)

Country Link
US (2) US5958432A (hu)
EP (1) EP0769293B1 (hu)
JP (1) JP3636473B2 (hu)
AR (1) AR004052A1 (hu)
BR (1) BR9611302A (hu)
CA (1) CA2222311C (hu)
DE (1) DE69603681T2 (hu)
DK (1) DK0769293T3 (hu)
FR (1) FR2740040B1 (hu)
HU (1) HUP9900511A3 (hu)
NO (1) NO312273B1 (hu)
PL (1) PL186366B1 (hu)
RU (1) RU2169552C2 (hu)
WO (1) WO1997015281A1 (hu)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5948972A (en) * 1994-12-22 1999-09-07 Kla-Tencor Corporation Dual stage instrument for scanning a specimen
AU2001282988B2 (en) 2000-07-26 2006-01-05 Atopic Pty Ltd Methods for treating atopic disorders
ITPD20010187A1 (it) * 2001-07-23 2003-01-23 Cutech Srl Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
EP1295599A1 (en) * 2001-09-21 2003-03-26 Boehringer Ingelheim International GmbH Method for the treatment of prevention of atopic dermatitis
US20030219573A1 (en) * 2002-03-27 2003-11-27 Torgny Falk Absorbent product
US8343519B2 (en) * 2003-02-19 2013-01-01 L'oreal S.A. Chemical enhancer and method
EP1613266A4 (en) * 2003-04-15 2009-05-06 Theraquest Biosciences Llc METHOD FOR TREATING PAIN AND COMPOSITIONS FOR USE THEREOF
EP1813285A4 (en) * 2004-11-19 2010-06-09 Kissei Pharmaceutical PROPHYLACTIC OR THERAPEUTIC AGENT AGAINST NEUROPATHIC PAIN
MY147864A (en) 2005-04-13 2013-01-31 Astion Dev As Beta-2 adrenoceptor agonists for treating connective tissue diseases of the skin
EP2252278B1 (fr) * 2008-01-18 2011-10-26 Centre National de la Recherche Scientifique - CNRS Agonistes béta-2 adrénergiques pour utilisation dans le traitement de l'allodynie neuropathique chronique
GB0805535D0 (en) * 2008-03-27 2008-04-30 Univ Leicester Scar prevention
US8420114B2 (en) * 2008-04-18 2013-04-16 Warsaw Orthopedic, Inc. Alpha and beta adrenergic receptor agonists for treatment of pain and / or inflammation
JP5425229B2 (ja) * 2009-02-24 2014-02-26 ノバルティス アーゲー Ｎｋ受容体アンタゴニストの使用
GB2513297A (en) 2013-03-08 2014-10-29 Univ Leicester Methods
EP3319607A4 (en) 2015-07-09 2019-04-03 Galderma S.A. METHOD FOR REDUCING HAIR LOSS IN CONNECTION WITH CHEMOTHERAPY
WO2019230230A1 (ja) * 2018-05-29 2019-12-05 株式会社ナノエッグ アトピー性皮膚炎を治療または予防するための組成物
AU2019336248A1 (en) * 2018-09-08 2021-05-13 Tan WEN New use of R-enantiomer of adrenergic β2 receptor agonists for treatment of inflammatory bowel disease and its extra intestinal manifestations

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1474316A (en) * 1975-02-12 1977-05-25 Seperic O-aminoalkyl oximes
US4038417A (en) * 1975-06-19 1977-07-26 Nelson Research & Development Company Method for treatment of psoriasis
US4525359A (en) * 1982-12-10 1985-06-25 Greenway Frank L Iii Treatment for selective weight control
US5366731A (en) * 1990-08-24 1994-11-22 Wisconsin Alumni Research Foundation Cosmetic compositions containing secosterol compounds
IL99368A (en) * 1991-09-02 1996-01-19 Teva Pharma Preparations for the treatment of psoriasis and atopic dermatitis, which contain the result of xanthine
CA2114968A1 (en) * 1993-02-25 1994-08-26 John Wille Transdermal treatment with mast cell degranulating agents for drug-induced hypersensitivity
JPH07258067A (ja) * 1994-03-18 1995-10-09 Kao Corp 浴用剤組成物
FR2719474B1 (fr) * 1994-05-05 1996-05-31 Oreal Utilisation d'un antagoniste de substance P dans une composition cosmétique et composition obtenue.

Also Published As

Publication number Publication date
WO1997015281A1 (fr) 1997-05-01
NO976143L (no) 1998-06-03
JP2000503628A (ja) 2000-03-28
JP3636473B2 (ja) 2005-04-06
BR9611302A (pt) 1999-03-30
EP0769293A3 (fr) 1997-05-02
DE69603681T2 (de) 1999-11-25
NO976143D0 (no) 1997-12-30
EP0769293B1 (fr) 1999-08-11
AR004052A1 (es) 1998-09-30
NO312273B1 (no) 2002-04-22
FR2740040B1 (fr) 1997-12-05
US5958432A (en) 1999-09-28
FR2740040A1 (fr) 1997-04-25
PL324924A1 (en) 1998-06-22
MX9710475A (es) 1998-08-30
DE69603681D1 (de) 1999-09-16
CA2222311A1 (fr) 1997-05-01
US6267972B1 (en) 2001-07-31
CA2222311C (fr) 2006-11-28
EP0769293A2 (fr) 1997-04-23
DK0769293T3 (da) 1999-12-06
PL186366B1 (pl) 2003-12-31
RU2169552C2 (ru) 2001-06-27
HUP9900511A3 (en) 2000-09-28

Similar Documents

Publication Publication Date Title
HUP9900511A2 (hu) Legalább egy béta-adrenergiás agonista alkalmazása P anyag antagonistaként és kozmetikai kezelési eljárás
BR9612204A (pt) Composto uso do composto composição farmacêutica e processo para preparação do composto e para o tratamento de dor
BR9609532A (pt) Composição antimicrobiana para o tratamento de cabelo processo para o tratamento de caspa e uso da composição
BR9704843B1 (pt) hidroxifeniltriazinas, composiÇço, processo de estabilizaÇço de material orgÂnico, uso, preparaÇço cosmÉtica e processo de tratamento de cabelo humano.
ATE311849T1 (de) Verwendung von kosmetische und pharmazeutische zubereitungen enthaltend 2-decarboxy-2-phosphino prostaglandinderivate
BR9303433A (pt) Composicao viscoelastica linear para a higiene ou cuidados pessoais,processo para a promocao da higiene e cuidados pessoais,processo para a fixacao dos cabelos,processo para a promocao da higiene e cuidados da pele,e,uso de um agente espessante polimerico
BR0204979A (pt) Composição cosmética destinada ao tratamento das fibras queratìnicas humanas que compreende um silicone aminado particular, processo de tintura de oxidação, de tratamento e descoloração das fibras queratìnicas humanas, e uso de pelo menos um silicone aminado
HUP9903906A2 (hu) Kelátképző clioquinol felhasználása Alzheimer-kór kezelésére alkalmas gyógyszerkészítmények előállításánál
DK241588A (da) Topisk haarvaekstmiddel
MX9801596A (es) Composiciones aliviadoras del prurito, cosmeticas y farmaceuticas o ambas.
MY107088A (en) Plaster used as therapeutic system for the administration of active substances to the skin, which exhibits a graduated active substance release,process for the production of the plaster and use thereof
DE69628296D1 (de) Verwendung von sophorolipiden zur herstellung kosmetischer produkte, insbesondere zur behandlung der haut
BR9903336B1 (pt) composição cosmética, usos da composição e processo para o tratamento cosmético de substáncias queratìnicas.
AU1958195A (en) Hygienic and cosmetic preparations for preventing and treating skin-diseases as well as a process for obtaining same
ES2144239T3 (es) Derivados de vitamina d con sustituyentes en c-25, procedimiento para su preparacion, productos intermedios y la utilizacion para la preparacion de medicamentos.
RU95103892A (ru) Композиция топического нанесения для стимулирования роста волос и/или замедления их выпадения, способ косметического лечения волос, применение производного альфа -пирона для получения композиции
UA35611C2 (uk) Композиція місцевого застосування для інгібування росту волос у ссавців, спосіб із її використанням та композиція місцевого застосування для доставки водорозчинного фармакологічного засобу до шкіри
HUP9900654A1 (hu) Körömnövekedést serkentő készítmény, eljárás előállítására és alkalmazása
HUP9700153A2 (hu) Glicerin-triacetát alkalmazása gombás körömmegbetegedés kezelésére alkalmazható gyógyászati készítmények előállítására
HUP9700806A2 (hu) Tianeptin-nátriumsó nyújtott felszabadulását biztosító, szájon át beadható mátrix tabletta és eljárás előállítására
HUP0000642A2 (hu) Izzadásgátló vagy dezodoráló készítmény, valamint eljárás előállítására
CA2232433A1 (fr) Nouvelle composition reductrice et nouveau procede pour la deformation permanente des cheveux
FR2653015B1 (fr) Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinouide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant.
BR9302646A (pt) Composicao cosmeticamente aceitavel,adequada para aplicacao topica a pele,cabelos ou unhas,e,processo para tal tratamento
BR9711649A (pt) Processo e agente para a modelagem permanente de fibras de queratina

Legal Events

Date Code Title Description
FD9A Lapse of provisional protection due to non-payment of fees